KITLG and neoplasm: Recent studies have shown that mast cells infiltrate tumors and tumor microenvironments and release many mediators (e.g., EGF, NGF, PDGF, SCF, angiopoietin, heparin, IL-8, and VEGF), thereby affecting tumor development, tissue remodeling, and tumor-adaptive immune responses [9,10].